NA
IDYA icon

NewEdge Advisors’s IDEAYA Biosciences IDYA Stock Holding History

NewEdge Advisors’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50
Closed -$1.76K – 3874
2024
Q2 		$1.76K Buy
+50
New +$1.98K ﹤0.01% 3363
2023
Q2 		– Sell
-92
Closed -$1.26K – 3557
2023
Q1 		$1.26K Hold
92
– – ﹤0.01% 3126
2022
Q4 		$2 Buy
+92
New +$1.55K ﹤0.01% 3944

Other funds holding IDYA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

NewEdge Advisors's IDYA Position: Q3 2024 in Review

NewEdge Advisors sold out of IDEAYA Biosciences (IDYA) in Q3 2024, closing a stake of 50 shares — an estimated $1.76K sold.

NewEdge Advisors first reported a position in IDYA in Q4 2022 and held it in 3 quarters. The position peaked at $1.76K in Q2 2024. 209 funds tracked by Wall St. Rank hold IDYA as of Q3 2024.

  • NewEdge Advisors reported no remaining IDEAYA Biosciences position as of Q3 2024 after selling out during the quarter.
  • NewEdge Advisors sold 50 IDEAYA Biosciences shares in Q3 2024, an estimated $1.76K.
  • NewEdge Advisors first reported a position in IDEAYA Biosciences in Q4 2022 and held it in 3 quarters.
  • NewEdge Advisors's IDEAYA Biosciences position peaked at $1.76K in Q2 2024.
  • 209 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q3 2024.

Based on NewEdge Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.